We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Blood Pressure Change and Outcome (BP)

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: April 6, 2011
Last Update Posted: May 5, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Renal Research Institute
Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been previously studied in dialysis population. The investigators aim to understand how both blood pressure levels and blood pressure changes over time predict patient survival.

Renal Disease High Blood Pressure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Relationship of Systolic and Diastolic Blood Pressure Changes Over Time to Patient Outcomes in Incident Hemodialysis Patients

Resource links provided by NLM:

Further study details as provided by Renal Research Institute:

Primary Outcome Measures:
  • Effect size of the relation of dynamic changes of blood pressure (BP) at different ranges of BP to survival in incident hemodialysis patients. [ Time Frame: Up to 11 years and 11 months ]
    The ranges of blood pressure measurements in mmHg over time and the relation to patient outcomes (including survival)

Enrollment: 12695
Study Start Date: January 1999
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Hemodialysis patients


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 88 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Renal Research Institute hemodialysis patients

Inclusion Criteria:

  • Hemodialysis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01330004

United States, New York
Renal Research Institute
New York, New York, United States, 10128
Sponsors and Collaborators
Renal Research Institute
Principal Investigator: Nathan W Levin, MD Renal Research Institute
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Renal Research Institute
ClinicalTrials.gov Identifier: NCT01330004     History of Changes
Other Study ID Numbers: 080-11
First Submitted: March 31, 2011
First Posted: April 6, 2011
Last Update Posted: May 5, 2015
Last Verified: May 2015

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases